KANJINTI vs VINBLASTINE SULFATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. KANJINTI and VINBLASTINE SULFATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KANJINTI	VINBLASTINE SULFATE
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TRASTUZUMAB-ANNS	VINBLASTINE SULFATE
Manufacturer	Amgen Inc	Quad Pharms
Dosage forms	Injectable	Injectable
Drug class	—	Vinca Alkaloid
Boxed warning	Boxed warning	None
Treats	Breast Neoplasms, Gastrointestinal Neoplasms	Breast Neoplasms, Choriocarcinoma, Head and Neck Neoplasms

kanjinti vinblastine sulfate

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

TRASTUZUMAB-ANNS

VINBLASTINE SULFATE

Manufacturer

Amgen Inc

Quad Pharms

Dosage forms

Injectable

Drug class

—

Vinca Alkaloid

Boxed warning

None

Treats

Breast Neoplasms, Gastrointestinal Neoplasms

Breast Neoplasms, Choriocarcinoma, Head and Neck Neoplasms

Frequently asked questions

What is the difference between Kanjinti and Vinblastine Sulfate?

Kanjinti contains Trastuzumab-Anns, while Vinblastine Sulfate contains Vinblastine Sulfate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.